90% are long, 10% are short on MSB. Its all about perspective. Shorts love the Bio space, most trials fail, most need CR, Most struggle to meet the high bar, set by the FDA, FACT. Its a natural fit for Shorter's. I think we focus on shorts way too much IMO.
MSB Price at posting:
$2.53 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)